Chemoinformaics analysis of (Z)-9-HYDROXYOCTADEC-12-ENOIC ACID
| Molecular Weight | 298.467 | nRot | 15 |
| Heavy Atom Molecular Weight | 264.195 | nRig | 22 |
| Exact Molecular Weight | 298.251 | nRing | 0 |
| Solubility: LogS | -4.518 | nHRing | 0 |
| Solubility: LogP | 2.898 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.137 |
| nHD | 2 | BPOL | 34.977 |
| QED | 0.724 |
| Synth | 3.08 |
| Natural Product Likeliness | 0.781 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.842 |
| Pgp-sub | 0.004 |
| HIA | 0.005 |
| CACO-2 | -4.848 |
| MDCK | 0.0000295 |
| BBB | 0.969 |
| PPB | 0.941348 |
| VDSS | 1.924 |
| FU | 0.0917343 |
| CYP1A2-inh | 0.829 |
| CYP1A2-sub | 0.941 |
| CYP2c19-inh | 0.044 |
| CYP2c19-sub | 0.895 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.771 |
| CYP2d6-inh | 0.51 |
| CYP2d6-sub | 0.925 |
| CYP3a4-inh | 0.729 |
| CYP3a4-sub | 0.812 |
| CL | 12.635 |
| T12 | 0.274 |
| hERG | 0.403 |
| Ames | 0.119 |
| ROA | 0.812 |
| SkinSen | 0.63 |
| Carcinogencity | 0.537 |
| EI | 0.012 |
| Respiratory | 0.898 |
| NR-Aromatase | 0.092 |
| Antiviral | Yes |
| Prediction | 0.556757 |